Open AccessAn open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine
Author(s) -
Norbert A. Foudraine,
J J de Jong,
G. J. Weverling,
Birgit Hb van Benthem,
Jolanda Maas,
I. P. M. Keet,
Suzanne Jurriaans,
Małgorzata Roos,
Kati Vandermeulen,
Frank de Wolf,
Joep M. A. Lange
Publication year - 1998
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199812000-00014
Subject(s) - stavudine , lamivudine , zidovudine , indinavir , medicine , virology , viral load , randomized controlled trial , gastroenterology , didanosine , reverse transcriptase inhibitor , pharmacology , biology , human immunodeficiency virus (hiv) , virus , viral disease , antiretroviral therapy , hepatitis b virus
To compare the antiretroviral effect and safety of zidovudine (ZDV)-lamivudine (3TC) with that of stavudine (d4T)-3TC.